MedTrace Logo

Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels

NCT04389034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2021-02-08

No results posted yet for this study

Summary

Primary goal of this non-interventional study is to evaluate the change in level of allergen-specific IgE (EAST class) after allergen-specific immunotherapy with Pollinex Quattro with tree and/or grass pollen extracts and their mixtures under medial routine at adults with tree- and/or grass-medicated pollinosis.

Conditions

  • Rhinitis, Allergic
  • Respiratory Tract Infections
  • Allergy
  • Allergic Asthma
  • Allergic Conjunctivitis

Interventions

DRUG

Pollinex Quattro with tree- and grass pollen extracts and their mixtures

retrospective analysis of patient records of allergen-specific immunotherapy

Sponsors & Collaborators

  • Allergy Therapeutics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2020-10-05
Completion
2020-10-05

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04389034 on ClinicalTrials.gov